Oscar Health Inc.

OSCR | NYSE

Price Alert Chart Builder DCF Calculator

$31.29

-$0.84 (-2.61%)

At close: Sep 21, 2026, 4:00 PM ET

$31.31

+$0.02 (+0.06%)

After-hours: Sep 21, 2026, 7:54 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $8.33B

Enterprise Value $-11.23M

Beta 2.37

Average Volume 6.56M

Shares Outstanding (Diluted) 333.43M

Shares Change YoY 23.38%

Institutional Ownership 58.52%

Exchange NYSE

ISIN US6877931096

Price Performance

Price Change 1M -2.7%

Price Change 3M 4.5%

Price Change 6M 156.3%

Price Change YTD 109.0%

Price Change 1Y 69.1%

Price Change 3Y 463.8%

Price Change 5Y 84.3%

1M CAGR (ann.) 21.1%

1Y CAGR (ann.) 80.8%

5Y CAGR (ann.) 12.9%

All-Time CAGR -1.4%

Valuation

PE Ratio 22.35

Forward PE 16.54

PEG Ratio 0.19

Forward PEG 0.82

PS Ratio 0.53

Forward PS 0.40

PB Ratio 3.95

P/FCF Ratio 1.87

P/Adj. FCF Ratio 1.90

P/OCF Ratio 2.16

EV/Sales -0.00

EV/EBIT -0.02

EV/EBITDA -0.02

EV/FCF -0.00

Earnings Yield 4.5%

FCF Yield 53.4%

Adj. FCF Yield 52.5%

Financial Health

Net Cash $8.12B

Total Debt $431.63M

Cash & Short-Term Investments $8.56B

Total Assets $11.23B

Current Ratio 1.08

Quick Ratio 1.08

Debt / Equity Ratio 0.21

Debt / EBITDA 0.68

Debt / FCF 0.10

OCF / Debt 10.13

Interest Coverage 39.37

Altman Z-Score 1.88

Piotroski F-Score 7

Margins & Profitability

Gross Profit Margin 44.9%

Operating Profit Margin 4.1%

EBITDA Margin 4.1%

Net Profit Margin 3.6%

FCF Margin 28.3%

Adj. FCF Margin 27.8%

SBC / Revenue 0.5%

SBC Impact (per share) -1.7%

Returns

Return on Assets 4.9%

Return on Equity 38.5%

Return on Invested Capital 23.0%

Return on Capital Employed 24.6%

Return on Tangible Assets 4.9%

Historical Growth (CAGR)

Revenue CAGR 3Y 44.8%

Revenue CAGR 5Y 64.8%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 474.5%

EPS CAGR 5Y 108.8%

EPS CAGR 10Y N/A

FCF CAGR 3Y 204.5%

FCF CAGR 5Y 80.8%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 13

EPS Growth Next 3Y 15.3%

Revenue Growth Next 3Y 17.1%

Earnings Date Nov 8, 2026

EPS Estimate (next Q) -$0.15

EPS Growth Est (next Q) -71.7%

Revenue Est (next Q) $4.69B

Revenue Growth Est (next Q) 57.2%

Fair Value Estimates

Graham Number $14.64

Graham Upside -53.2%

Lynch Fair Value $35

Lynch Upside 11.9%

Price Target $34

Price Target Upside 8.7%

Cash Flow

Operating Cash Flow $4.37B

Free Cash Flow $4.33B

Adj. Free Cash Flow $4.26B

FCF Per Share $14.34

OCF Per Share $14.47

OCF/S Ratio 28.6%

Income Statement

Revenue $15.32B

Gross Profit $6.88B

Operating Income $624.1M

EBITDA $633.73M

Net Income $550.74M

EPS (Diluted) $1.40

Revenue / Employee $6.65M

Profit / Employee $238.93K

Employees 2,305